Substituted heterocycle fused gamma-carbolines

Details Substituted heterocycle fused gamma-carbolines Substituted heterocycle fused gamma-carbolines

2006-07-25

2006-07-25

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S212060, C514S214020, C514S214030, C514S286000, C514S288000

Reexamination Certificate

active

07081455

ABSTRACT:
The present invention is directed to methods of treating addictive behavior and sleep disorders by administering compounds represented by structural Formula (I)or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6a, R6b, R7, R8, R9, X, b, k, m, and n, and the dashed lines are described herein. The compounds used in the method of treatment of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including addictive behavior and sleep disorders.

REFERENCES:
patent: 3299078 (1967-01-01), Pachter
patent: 5512575 (1996-04-01), Jacobs et al.
patent: 5654139 (1997-08-01), Lappalainen et al.
patent: 5902815 (1999-05-01), Olney et al.
patent: 5908830 (1999-06-01), Smith et al.
patent: 6107324 (2000-08-01), Behan et al.
patent: 6140509 (2000-10-01), Behan et al.
Bickerdike MJ, Vickers, SP, Dourish CT, (1999) 5-HT2C receptor modulation and the treatment of obesity. Diabetes, Obesity and Metabolism 1:207-2140.
Tecott LH, et al. (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature (London) 374:542-546.
Cryan JF, Lucki I, (2000) Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors. J. Pharmacol. Exper. Ther. 295:1120-1126.
Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S, (1997) 5-HT2C receptors mediate penile erection in rats: actions of novel and selective agonists and antagonists. Eur. J. Pharmacol. 325:9-12.
Martin JR, et al. (1998) 5-HT2C receptor agonists: Pharmacological characteristics and therapeutic potential. J. Pharmacol. Exper. Ther. 286:913-924.
Meltzer HY. (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21(2):1065-1155.
Curzon et al, Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability, TiPS, vol. 18, 1997; 21-25.
Mora et al, Role of 5-HT2A and 5-HT2C Receptor subtypes in the Two Types of Fear Generated by the Elevated T-Maze, Pharma. Biolchem. & Behavior, vol. 58, No. 4, 1997; 1051-1057.
Jenck et al, Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats, European Neuropsychopharmacology, 8, 1998; 161-168.
Leysen, Selective 5-HT2c agonists as potential antidepressants, Drugs, 1999, 2(2); 109-120.
Jenck et al, The role of 5-HT2c receptors in affective disorders, Exp. Opin. Invest. Drugs, 1998, 7(10); 1587-1599.
Kennett, 5-HT drugs and eating disorders, I Drugs, 1998, vol. 1, No. 4; 456-470.
Brewerton, Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine, Clin. Pharmacol. Ther., 1988, 605-609.
Kahn et al, m-Chlorophenylpiperazine as a probe of serotonin function, Biol. Psychiatry, 1991; 30: 1139-1166.
Gibson et al, Evidence that mCPP-induced Anxiety in the Plus-maze is mediated by Postsynaptic 5-Ht2c receptors but not by sympathomimetic effects, Neuropharmacology, vol. 33, No. 3, 4, 1994; 457-465.

Affiliated with

Also associated with

Rating

Substituted heterocycle fused gamma-carbolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted heterocycle fused gamma-carbolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocycle fused gamma-carbolines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3572811